Pure Global

Typhoid IgG/IgM test - India CDSCO Medical Device Registration

Typhoid IgG/IgM test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000136_2b988b32aa4214345bb08b50fff0fefc_4679222d916ca1f8fe77d58ddf616d72. The license holder is Seloi Healthcare Pvt Ltd, and it is classified as Device Class Class B. The approving authority is Greater Mumbai Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Typhoid IgG/IgM test
UID: MFG/IVD/2022/000136_2b988b32aa4214345bb08b50fff0fefc_4679222d916ca1f8fe77d58ddf616d72

Device Class

Class B

Approving Authority

Greater Mumbai Division

Product Information

The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi ##PLACEHOLDER_0## IgG and IgM in human serum and plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM Rapid Test must be confirmed with alternative testing method##PLACEHOLDER_0##.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing